Search

Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.

Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.

• Case study - research
• Written

Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.

• News

Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).

Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.

Retina UK employs a team of staff at our offices in Buckingham and remotely around the UK. Details of any vacancies will be posted below.

We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.

Prof John Marshall is the Frost Professor of Ophthalmology at the Institute of Ophthalmology at University College London.

• Trustee
• Written